Skip to Content

Clinical Trials Search Results

Showing 1-3 of 3

Sorted By:

  • CTSU E1A11

    Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)

  • Millennium C16014

    A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma

  • SWOG S1304

    A Phrase II randomized study comparing Two doses of Carfilzomib (NSC-756640) with Dexamethasone for Multiple Myeloma patients with Relapsed or Refractory disease

Showing trials 1-3 of 3

Also in this Section